Jolly Pharmaceutical industry to issue 20 million shares

Panorama January 25 Jolly Pharmaceutical Industry (300181) in the evening in the giant Tide information Network issued a letter of intent. The company intends to issue 20 million shares, issued after the total share capital of 80 million shares.　　The unit will be implemented on February 10, 2011 online, web-based purchase, and will be listed on the gem.　　This issue adopts the network to the placing of the object of the placing of the allocation and online to the social public investors in the form of a combination of pricing issues, of which under the net issue accounted for the final issue of the number of 20%, that is 4 million shares; The number of the online issue is the final issue quantity minus the net　　According to the issue schedule, the date of the inquiry is January 27-January 31, the pricing notice is published on February 9, the date of purchase and the payment date is February 10, and will apply for listing on the Shenzhen Stock Exchange as soon as possible after the release.　　Zhejiang Jolly Pharmaceutical Co., Ltd. specializes in drug research and development, production and sales, based on the medicinal fungi bio-fermentation technology production of traditional Chinese medicine products, the realization of rare Chinese herbal medicine-Wuling Ginseng industrialization production, to achieve the traditional Chinese herbal medicine and modern biotechnology application of the combination. The release of the funds will be mainly invested in the following five projects: The new annual production of 200 tons of wuling powder manufacturing technology upgrading and expansion of the project, new annual output of 450 million capsules construction projects, pharmaceutical fungi research and development center construction projects, marketing network construction projects and other business related to the operating capital. Total project investment is 167 million yuan. (Panoramic net/thunder)